MarketPulse

neurodegeneration

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Abli Therapeutics

ABLi Therapeutics Bolsters Board with Roche Neurology Veteran Ahead of Phase 3 Push

ABLi Therapeutics appoints Dr. Rachelle Doody, Roche neurology veteran, to board as company advances risvodetinib into Phase 3 trials for Parkinson's and related diseases.
RHHBYPhase 3 clinical trialdrug development
GlobeNewswire Inc.GlobeNewswire Inc.··Seer, Inc.

Seer Showcases Proteograph Platform at US HUPO 2026 Conference

Seer presents its Proteograph platform at US HUPO 2026, showcasing proteomics research across cardiovascular, neurodegenerative, aging, and oncology applications using minimal sample volumes.
SEERproteomicsProteograph Product Suite